Diebold Nixdorf Inc DBD shares are trading lower by $5.75 (20.3 percent) at $22.25 in Wednesday's session.
The catalyst for the major decline is the company's reduced FY 2017 EPS and sales guidance. EPS was reduced to $0.95-$1.15 vs. $1.59 estimates and sales guidance was reduced to $4.7-$4.9 billion vs. $4.99 billion estimates.
After a much lower open, it only managed a 20-cent bounce to $25.00 before continuing its move lower. The ensuing decline took the stock to $21.75 but rebounded back into the $22.00 handle.
The current low coincides with its December low of $21.92.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.